What to know
- Monkeypox is diagnosed using real-time PCR tests available through health department and many large commercial laboratories.
- You can minimize the risk of laboratory transmission when testing routine clinical specimens from confirmed or suspected monkeypox patients.
- CDC has procedures, recommendations, and resources to help keep healthcare and laboratory workers safe when collecting samples and testing for monkeypox virus.

Overview
Timely and comprehensive laboratory testing and results reporting is a critical piece of the public health response to monkeypox.
These data help public health officials understand more about the spread of monkeypox virus (MPXV). Any laboratory that performs diagnostic testing for monkeypox should report test results to state, tribal, local, or territorial health departments. This includes real-time polymerase chain reaction (PCR) testing for orthopoxvirus, non-variola orthopoxvirus (NVO), or MPXV.
Reporting results and biosafety
Important information
- Confirmed clade I MPXV is classified as a Tier 1 Select Agent, and some specific federal regulations and guidelines apply to work conducted with the virus. Clade II MPXV no longer is classified as a Select Agent.
- Report all qualitative results unless otherwise specified by the applicable health department. Report positive results use standardized LOINC and SNOMED-CT codes within 24 hours of testing to the appropriate health department.
- As with all biological agents, laboratory safety is of the utmost importance. Consult the Biosafety in Microbiological and Biomedical Laboratories (BMBL) 6th Edition for more information about handling MPXV. The BMBL and ACIP also have recommendations for vaccination for laboratorians working with MPXV.